Stock Analysis: Alnylam Pharmaceuticals (NASDAQ: ALNY)
About Alnylam Pharmaceuticals Alnylam is your run of the mill biopharmaceutical company. It has certain products it specializes in that separate itself from the competition, as is the case from other pharmaceutical companies, small and large. According to TD Ameritrade’s platform, Alnylam primarily focuses on and is “developing therapeutics based on ribonucleic acid interference (RNAi),” […]
Stock Analysis: Alnylam Pharmaceuticals (NASDAQ: ALNY) Read More »